EDGAR Filing Documents for 0001144204-17-044417

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-17-044417

Filing Date

2017-08-21

Accepted

2017-08-21 16:41:53

Documents

Period of Report

2017-08-21

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v473717_6k.htm	6-K	20004
2	EXHIBIT 10.1	v473717_ex10-1.htm	EX-10.1	125559
3	EXHIBIT 99.1	v473717_ex99-1.htm	EX-99.1	12340
	Complete submission text file	0001144204-17-044417.txt		159102

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 171043450
SIC: 2834 Pharmaceutical Preparations